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Abstract
Cases of canine neural angiostrongylosis (NA) with cerebrospinal fluid (CSF) evaluations in the peer-reviewed literature
were tabulated. All cases were from Australia. A retrospective cohort of 59 dogs was contrasted with a series of 22 new
cases where NA was diagnosed by the presence of both eosinophilic pleocytosis and anti-Angiostrongylus cantonensis
immunloglobulins (IgG) in CSF, determined by ELISA or Western blot. Both cohorts were drawn from south east
Queensland and Sydney. The retrospective cohort comprised mostly pups presented for hind limb weakness with
hyperaesthesia, a mixture of upper motor neurone (UMN) and lower motor neurone (LMN) signs in the hind limbs and
urinary incontinence. Signs were attributed to larval migration through peripheral nerves, nerve roots, spinal cord and
brain associated with an ascending eosinophilic meningo-encephomyelitis. The contemporary cohort consisted of a
mixture of pups, young adult and mature dogs, with a wider range of signs including (i) paraparesis/proprioceptive
ataxia (ii) lumbar and tail base hyperaesthesia, (iii) multi-focal central nervous system dysfunction, or (iv) focal disease
with neck pain, cranial neuropathy and altered mentation. Cases were seen throughout the year, most between April
and July (inclusive). There was a preponderance of large breeds. Often littermates, or multiple animals from the same
kennel, were affected simultaneously or sequentially. A presumptive diagnosis was based on consistent signs, proximity
to rats, ingestion/chewing of slugs or snails and eosinophilic pleocytosis. NA was diagnosed by demonstrating anti-A.
cantonensis IgG in CSF. Detecting anti-A. cantonensis IgG in serum was unhelpful because many normal dogs (20/21 lb
dogs; 8/22 of a hospital population) had such antibodies, often at substantial titres. Most NA cases in the contemporary
series (19/22) and many pups (16/38) in the retrospective cohort were managed successfully using high doses of
prednisolone and opioids. Treatment often included antibiotics administered in case protozoan encephalomyelitis or
translocated bacterial meningitis was present. Supportive measures included bladder care and physiotherapy. Several
dogs were left with permanent neural deficits. Dogs are an important sentinel species for NA. Human cases and
numerous cases in tawny frogmouths were reported from the same regions as affected dogs over the study period.
Background
Angiostrongylus cantonensis is a metastrongyloid nema-
tode that normally lives in the right ventricle and pul-
monary arteries of rats, its definitive (permissive) host
[1]. While many species of rats can carry patent infec-
tions, the Norwegian rat (Rattus norvegicus)a n dt h e
black rat (Rattus rattus) are considered the most
important definitive hosts. In wild populations of rats,
A. cantonensis infections cause little disease, as expected
for an efficient parasite [1-3]. Dogs, humans, horses,
Australian native mammals (e.g. possums, macropods,
macrobats) and birds (e.g. tawny frogmouths), and var-
ious zoo animals are non-permissive “accidental” hosts
that become infected after ingesting third-stage larvae
(L3) in intermediate hosts (molluscs) [1,4] or transport
hosts (such as planarians, frogs, fish and crustaceans)
[5-7]. Tawny frogmouths and Australian marsupials are
highly susceptible to clinical neural angiostrongylosis.
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any medium, provided the original work is properly cited.In rats, following digestion, L3 migrate from the gut to
peripheral nerves, nerve roots, spinal cord and brain [8].
A. cantonensis shows obligate neurotropism, i.e. larvae
must migrate through the central nervous system (CNS)
before taking up residence in the pulmonary arteries,
w h e r et h e ys u b s e q u e n t l ym a t ea n dp r o d u c ee g g sw h i c h
embolise in the pulmonary capillary bed. Larvae migrate
up the trachea, then are coughed up, swallowed and
passed in the stool, where they access intermediate mol-
lusc hosts (slugs or snails). Virtually all species of native
and introduced terrestrial molluscs in Australia are sui-
table intermediate hosts [1].
Larval neurotropism dominates disease pathogenesis in
non-permissive hosts liked o g sa n dp e o p l e .I nh u m a n
patients, signs of NA include headache, fever, nausea,
vomiting, neck stiffness, paraesthesia, face or limb paraly-
sis, photophobia, diplopia, coma, seizures and even death
[9-11]. Canine NA usually results from ingestion of slugs,
snails or paratenic hosts containing infective L3 [12-15].
After ingestion, larvae leave the gut, typically via intest-
inal veins and lymphatics. They then travel up peripheral
nerves and nerve roots, subsequently moving cranially
within the spinal cord parenchyma or via the subarach-
noid space. They damage CNS tissues via two mechan-
isms. Firstly, there is neural injury and haemorrhage
(mechanical damage and cavitations) consequent to the
migration process [16,17]. Additionally, intense eosino-
philic meningo-encephalomyelitis is triggered by larval
antigens, most likely metabolic, excretory or moulting
products [18-20]. Thus, combinations of pathomechan-
isms injure the CNS in various locations and through dif-
ferent processes, resulting in a range of neurologic signs.
The use of anthelmintics (e.g. levamisole, benzimidazoles,
avermectins) cause larvae to die, which ends the mechan-
ical damage but greatly increase parasite-derived eosino-
philic inflammation, due to sudden release of cytoplasmic
metazoan antigens and cessation of production of para-
site-derived immunosuppressant molecules.
Three elements are required for infection to occur: (i)
the presence of rats, (ii) the presence of a suitable inter-
mediate mollusc hosts and (iii) the opportunity for the
potential host to eat (or chew) infected definitive, inter-
mediate or paratenic hosts. In Australia, the disease in
dogs (especially pups) was well known in south east
Queensland as a result of seminal studies by Ken Mason
and colleagues in the 1970s [21,22]. As a result, cases
are commonly diagnosed and treated in general practice.
Although some of this work is published, the actual
Master’s dissertation [14] contains additional pertinent
information. Subsequently, the disease was reported in
an increasing variety of native and domestic species,
initially in Queensland and later in Sydney. The expan-
sion of disease was likely attributable to extension in the
geographic range of some critical mollusc host. In the
early 1990s, disease in pet dogs was reported for the
first time in Sydney, and subsequently has been seen
increasingly as a life-threatening cause of neurologic dis-
ease in dogs, horses, macropods, possums, macrobats,
birds (tawny frogmouths) and animals in zoological col-
lections (especially monkeys) throughout its geographic
range along eastern Australia. It has likewise become a
cause of life-threatening neurologic disease in humans
over the same range, especially in infants (who have a
propensity to eat slugs and snails) [11] and inebriated
adult males (typically inebriated young men who eat a
snail for a dare, typically at a “buck’s night”).
In 2003, two of the authors (JL & RM) encountered
the disease in a young dog [23]. This provided the
impetus to utilise a relatively specific serological test,
thus permitting more definitive diagnosis of NA based
on detecting Ig directed against A. cantonensis rather
than making a presumptive diagnosis based on consis-
tent signs and an eosinophilic pleocytosis. The further
refinement and validation of ELISA and Western blot
assays for NA permitted the authors to re-examine the
range of clinical findings in dogs with eosinophilic
meningoencepalomyelitis/encephalitis, to determine
whether there was a wider spectrum of neurologic
sequelae to infection with A. cantonensis.
This article has two components: a review of the
canine literature and a new series of cases collected pro-
spectively with the help of colleagues in practice and
veterinary pathologists. The findings of this contempor-
ary study are examined in relation to the human and
experimental literature concerning NA.
Methods
A. Literature review of documented cases
Relevant papers concerning NA in dogs were identified
by searching Commonwealth Agricultural Bureau (CAB)
and OVID Medline databases using the key words “can-
tonensis” and “d o go rd o g so rc a n i n e ”. Data concerning
clinical findings, CSF cytology, necropsy observations
and serology were collated. Only cases with CSF analysis
were included in the study cohort. In the largest
recorded case series of NA, a grading scale was used to
divide patients into groups based on the severity of clin-
ical signs [14]. Grade 1 cases had hind limb involvement
and were mildly affected, Grade 2 cases progressed to
involve the forelimbs and occasionally the cranial nerves,
while Grade 3 cases progressed rapidly to severe gener-
alised paralysis and hyperaesthesia, and were euthanased
on humane grounds.
B. Contemporary case series
Case recruitment
Hospital records and clinicopathologic data from dogs
with suspected NA were recruited from practices in the
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and May 2005. A letter was sent to all registered Small
Animal Specialists and Veterinary Pathologists in
Queensland and New South Wales outlining the study
aims and samples desired from suspect NA cases (Addi-
tional file 1: Appendix 1). After contact with the pri-
mary clinician, a questionnaire (Additional file 2:
Appendix 2) was sent to determine the onset of the
signs, disease features, clinical course, administration of
parasiticides and exposure to intermediate hosts. Data
including signalment, presenting complaints, clinical
pathology (including necropsy findings) and treatment
outcomes were collected. CSF and/or serum specimens
were obtained, where possible, for serological studies.
Samples were stored at -80°C prior to analysis.
Inclusion criteria
Case inclusion was typically based on a presumptive diag-
nosis of NA, i.e. cases with progressive neurologic signs, a
history of ingesting rats, snugs or snails, proximity to rats
and eosinophilic pleocytosis in CSF. A more definitive
diagnosis was based on identifying nematode larvae
within the CNS at necropsy or detecting specific Ig
against A. cantonensis in CSF. Of 30 dogs considered
initially, only 22 had CSF cytology data (and thus CSF
available for ELISA and/or Western blot testing for anti-
A. cantonensis Ig). These 22 dogs were recruited into the
study. No cases in this prospective group were confirmed
at necropsy. Dogs with an atypical presentation were
included only if they were positive for Ig against A. canto-
nensis. Six dogs (a litter of greyhound pups) had strong
epidemiologic support for a diagnosis of NA, including
positive necropsy in one pup and were only included as a
footnote. CSF findings were unavailable for two pre-
sumptive cases, which were therefore not included.
Treatment
All dogs were treated with analgesic and supportive
care, as required, plus glucocorticoids (dexamethasone
[initially in some cases] and/or prednisolone). Suppor-
tive care included opioids, intravenous fluid therapy,
urinary catheterisation or manual expression of the
bladder, antimicrobials and passive physiotherapy. Pre-
dnisolone dosage ranged from 0.5 to 2 mg/kg (divided
daily); the dose was subsequently tapered over an
extended period, typically 6-12 weeks. A minimum of 4
weeks glucocorticoid therapy was given in all instances.
No dogs were given anthelmintics as part of the treat-
ment regimen, although some had been administered
prior to diagnosis as part of routine heartworm/flea
prophylaxis.
C. Detection of anti-A. Cantonensis antibodies
ELISA methods
Serum and CSF from suspected cases of NA were
tested using an ELISA developed by one of the authors
(RL). Positive and negative controls were tested also.
IgG against A. cantonensis was detected by an indirect
ELISA, adapted from the method of Cross & Chen
[24]. Methods for obtaining antigen are outlined in
Additional file 3: Appendix 3. The technique used to
perform the ELISA is described briefly, as follows. The
extract of adult A. cantonensis (crude antigen) was
coated onto Maxisorb plates at a concentration of 5
μg/mL. Serum and CSF were diluted to 1:100 in
“Blotto”. Two-fold, serial dilutions of 1:100 serum or
CSF were made. Dilutions from 1:100 to 1:204,800
were tested in each assay. The secondary antibody,
rabbit anti-dog IgG, conjugated to horseradish peroxi-
dase (HRP), was added to each well at a concentration
of 1:1,000. Primary and secondary incubation steps
were carried out at 37°C for 1 h with washes in dis-
tilled water between steps. Substrate was allowed to
react for 5 min at room temperature and then stopped
with 1 M phosphoric acid. Wells were read at 450 nm
using a Tecan plate reader.
ELISA cut-off values
The titre of serially diluted serum or CSF was calculated
by comparison with the optical density (OD) of three
known negative controls (mature adults pound dogs
that were clinically normal in all respects). Serum and
CSF from a necropsy-confirmed case of NA were used
as positive controls. Validation of the ELISA using con-
trol specimens is illustrated in Figures 1 and 2. The OD
of 1 to 3 negative sera and 1 negative CSF specimen
were determined at a dilution of 1:100 for each batch of
specimens tested. The same positive and negative con-
trols were used for each batch of specimens assayed.
The mean of the control serum or CSF samples, plus
three standard deviations (SD) was considered the cut-
off value above which the next dilution of the unknown
serum or CSF was considered positive (Figure 1). Based
on the results, using the cut-off values as described
above, descriptive statistics were calculated.
Western blot analysis
Many serum and CSF specimens were also tested for A.
cantonensis antibodies using an assay developed by one
of the authors (JS) as a component of a project concern-
ing NA in macropods [25]. Detection of IgG to adult A.
cantonensis antigens was carried out on specimens using
Western blot analyses. The technique has been
described in detail elsewhere [25]. Briefly, polyacryla-
mide gel electrophoresis in sodium dodecyl sulphate
(SDS-PAGE) was used to separate antigens of an adult
A. cantonensis preparation. The electrophoresed proteins
were transferred to a nitrocellulose membrane via a
semi-dry technique [26]. The antigen-infused nitrocellu-
lose membrane was incubated overnight at room tem-
perature with the test specimen. Following a final wash,
the membrane was incubated with a secondary antibody,
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solution was then added.
Based on human serological studies, the 31 kDa and
t h e2 0 4k D aa n t i g e n sw e r eu s e dt od e t e r m i n et h ep r e -
sence or absence of IgG to A. cantonensis [27-31]. The
molecular weight (MW) of the observed bands was
determined for each nitrocellulose strip by comparison
with the migration of known MW markers. CSF speci-
mens were considered positive if there were either dis-
crete bands or wider strips of colour at an apparent
MW of 31 or 204 kDa. The serum antibody response
was measured subjectively by visualising the density of
the band and graded as either negative (-), weakly posi-
tive (+), positive (2+) or strongly positive (3+). For pur-
poses of this study, all positive responses were grouped
together.
Control serum and CSF specimens
Samples of CSF and/or serum were collected from two
groups of dogs for use as negative controls. Samples
were obtained from 21 dogs (Group A) euthanased at
pounds during September 2005. The age of these dogs
was unknown but based on physical appearance and
dentition, they were probably less than one year old. All
were cross-breds. There were 14 entire males and 7
females of unknown reproductive status. Immediately
after euthanasia, blood was collected by percutaneous
cardiac puncture and CSF by cisternal tap. Serum was
harvested from heart blood. A small section of the
spinal cord was obtained from a region adjacent to the
cisterna magna. The presence or absence of inflamma-
tion within cord sections was determined histologically.
A second group of controls (Group B) consisted of cli-
ent-owned dogs presenting for reasons unrelated to pos-
sible infection with A. cantonensis. Serum was collected
from dogs undergoing routine desexing or orthopaedic
procedures during May 2005. None of these cases had
neurologic dysfunction. Twenty-two dogs of mixed ages
and breeds provided serum samples. There were 15
males and 7 females; 10 of the males were castrated and
four of the females were spayed. The median age of the
group was 4 years (range: 5 months to 12 years), i.e.
older than Group A dogs. All Group B dogs were on
heartworm (Dirofilaria immitis) prophylaxis and were
regularly treated with anthelmintics for intestinal para-
sites. Details of Control Group B are summarised in
Additional file 4: Appendix 4.
Results
A. Cases recorded previously
Signalment
The literature contained descriptions of 59 dogs with
naturally-occurring NA based on CSF cytology, clinical
findings or necropsy data [13-15,32]. Published case
details are summarised in Additional file 5: Appendix 5.
Of the 59 cases, only 38 met the inclusion criteria (i.e.
availability of CSF data). Thirty-seven were published by
Mason [14] from south-eastern Queensland, with only
o n eb yC o l l i n set al. [32] from Sydney.
A The median
age of this retrospective cohort was 10 weeks (range 6
Figure 1 Calculation of ELISA cut-off value. The optical density
(OD) of three negative control sera was determined at serum
dilutions of 1:100 to 1:512,000. E.g., for the dilution of 1:100:
negative control 1 = 0.011, negative control 2 = 0.008, negative
control 3 = 0.044. The mean (x) and standard deviation (SD) of
these three negative sera were calculated, viz. x = 0.021, SD = 0.02.
The cut-off value was taken as x + 3SD, in this example 0.083. Thus,
an OD value above this value was considered positive. The antibody
titres for test samples 1 and 2 were determined to be 1:100 and
1:800, respectively (i.e. where the line interpolated between the dots
crosses the red cut-off threshold), but the titre for sample 3 was
zero. Thus, test sample 1 and 2 are considered positive.
Figure 2 ELISA results for serum and CSF from case 3 of our
series. Note the optical density in the serum sample is still positive
one year after therapy, but much lower than at the time of
presentation.
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shown in Figure 3 and Additional file 6: Appendix 6;
cases tended to present between April and July. Of the
38 cases, 23 had siblings affected (i.e. two or more
members of a litter affected simultaneously or sequen-
tially). Breeds represented are listed in Table 1. Of the
38 cases, 31 (82%) were large or giant breed dogs and
14 (37%) were racing greyhounds. There were 23 males
and 15 females, none of which were desexed.
History and clinical presentation
All cases had bilateral hind limb paresis, hind limb mus-
cle wasting, urinary bladder paresis/incontinence, tail
paresis and hyperaesthesia. Less common findings
included gastrointestinal signs (vomiting, diarrhoea) and
various neurologic deficits (cranial nerve palsies, faecal
incontinence, convulsions or coma).
Clinical pathology
Haematology was performed in most instances. The
only consistent finding was peripheral eosinophilia. CSF
demonstrated an eosinophilic pleocytosis (Figure 4;
Table 2). The median eosinophil count within CSF was
1,185 cells/μL (range: 20 to 6,743 cells/μL). The median
percentage of eosinophils was 81% (range: 22% to 100%).
Treatment outcomes
All dogs received supportive care viz. manual expres-
sion of the urinary bladder and passive range of
motion exercises. Many cases received empiric antibio-
tic therapy (details not available). Betamethasone (1 to
2 mg/kg) was administered subcutaneously or orally
for 3 to 7 days. The mortality rate was 58% (22/38
dogs not surviving). The initial severity of the clinical
signs did not appear strongly associated with outcome;
9 of the 20 dogs (45%) classified as Grade 1 were
euthanased, 5 of the 11 (45%) Grade 2 dogs were
euthanased or died, while all of the Grade 3 cases were
euthanased. Only one dog received anthelmintics (Case
3; Grade 3) but it was euthanased soon after treatment
commenced. Of the remaining 16 cases that survived,
at least 3 cases (Cases 2, 50 and 51) had permanent
neurologic deficits.
B. Contemporary study
Signalment
Samples of serum and or CSF from 22 dogs with pre-
sumptive NA were collected between January 2002 and
May 2005. There were 8 males (4 castrated) and 14
females (7 spayed). No breed predisposition was
d e t e c t e d ,a l t h o u g h1 3( 5 9 % )o ft h ed o g sw e r el a r g e
breeds. Specifically, there were 3 cross breds, 3 Labrador
retrievers, 2 each of Boxers, Kelpies, Golden Retrievers
and Staffordshire Bull Terriers, and one each of Maltese,
Cattle Dog, Beagle, British Bulldog, Dobermann, Ger-
man Shorthair Pointer, Miniature Poodle and Rhodesian
Ridgeback. The median age of cases was 28 weeks
(range: 8 weeks to 10 years). None of the cases had litter
mates affected.
B Most (64%) of cases were presented
Figure 3 Geographic and temporal distribution of prospective cases in the Sydney region. Individual cases are indicated by a red dot on
the map on the left, and in purple columns (y axis - number of cases; x axis - month of the year) in the schematic on the right.
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Case No. Breed Age
(weeks)
Gender Month CSF
Protein
(g/L)
CSF Nucleated cell
count (cells/μL)
CSF Eosinophils Necropsy confirmed (NA
larvae present)
Number
(cells/μL)
%
nucleated
cells
Mason
a
Case 2 Border
Collie
9 M October 0.12 4200 3696 88% ?
Case 3* Daschund 14 M January N/A 7125 6056 85% No
Case 13* Kelpie 6 F December N/A 3680 2760 75% No
Case 14* Kelpie 7 M December N/A 1300 1053 81% No
Case 15* Labrador 8 F April N/A 2307 2030 88% No
Case 16* Greyhound 10 F July 0.43 4600 3404 74% Yes
Case 17* Greyhound 8 M July N/A 2700 1782 66% Yes
Case 18* Greyhound 10 M July 1.62 7750 6743 87% Yes
Case 19* Greyhound 9 M July 0.13 284 244 86% No
Case 20* Greyhound 10 F May N/A 265 98 37% No
Case 21* Corgi 9 F April 2.3 1350 1053 78% No
Case 22* Labrador 7 M December N/A 90 55 61% No
Case 27* GSD 7 F February N/A 1250 1025 82% Yes
Case 28* GSD 7 M February 0.2 2264 1449 64% No
Case 29* Greyhound 8 M April 0.25 2812 2418 86% No
Case 31* Greyhound 10 F June 0.32 1280 1139 89% No
Case 32 Greyhound 11 F June 0.18 3250 2633 81% ?
Case 33 Greyhound 11 M June 0.19 1465 1231 84% ?
Case 34 Greyhound 11 F June 0.23 240 226 94% ?
Case 35 Labrador 11 M April N/A 20 20 100% ?
Case 36 Afghan 11 M June 0.43 2300 1702 74% ?
Case 37 Beagle 10 M May 0.12 83 59 71% ?
Case 38* OESD 9 F July 0.4 2376 1925 81% Yes
Case 39 OESD 10 M July 0.11 7106 6680 94% ?
Case 40 OESD 9 F July 0.12 1197 1029 86% ?
Case 41 OESD 9 M July 0.12 2510 2309 92% ?
Case 42 Borzoi 8 F November N/A 512 435 85% ?
Case 43* Daschund 12 M October N/A 2800 1652 59% Yes
Case 44 Greyhound 8 M July 0.92 700 462 66% ?
Case 45* Greyhound 10 M May N/A 1760 1390 79% Yes
Case 46* Greyhound 9 M July 2.1 450 95 21% Yes
Case 49 Labrador 12 F November N/A 406 256 63% ?
Case 50 Great Dane 20 F April 0.9 1590 350 22% ?
Case 51 Great Dane 28 M February 0.6 2750 2063 75% ?
Case 52 Poodle 14 M May 2.4 250 150 60% ?
Case 53* Weimaraner 12 F April 0.5 490 441 90% ?
Case 54* Greyhound 16 M May N/A 2880 2304 80% Yes
Collins et
al. *
b
Bull Terrier 9 M May 0.54 886 886 100% Yes
Median 10 June 1185 81%
OESD - Old English Sheep dog
GSD - German Shepherd dog
*Died or euthanased
N/A - not available
?- not known
aMason [14]; Collins et al. [32]
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Figure 3 shows the geographic distribution of cases in
the Sydney metropolitan area, suggesting that the para-
site is not concentrated in particular suburbs.
History and presenting complaints
Only one dog (Case 5) was observed eating slugs and
snails. The route of infection for the remaining 21 cases
was not identified, although several clients mentioned
Figure 4 Cytospin smear of CSF specimen from Case 2 (contemporary series) stained with DiffQuik showing eosinophilic pleocytosis.
Two eosinophils are marked with a black arrow, although many more are present in the smear. A macrophage is marked with an arrowhead.
Segmented neutrophils are present also.
Table 2 Signalment and CSF cytology of contemporary cases of NA
CSF Data
Case No. Breed Age (weeks) Gender Month Protein (g/L) Nucleated Cells (× 10
6/L) Eosinophils
cells/μL%
1 Labrador 24 M May 0.3 270 232 86%
2 Golden Retriever 20 F May 0.5 4660 3,821 82%
3 Kelpie 24 F May 0.28 182 173 95%
4 Golden Retriever 16 F March 0.55 458 412 90%
5 Boxer 16 F May 0.55 458 389 85%
6 Miniature Poodle 16 M May 1.35 332 282 85%
7 Cross Bred 16 M June 1 146 145 99%
8 Beagle 20 F July 0.61 3651 3,505 96%
9 Australian Cattle Dog 48 F February 0.55 5952 4,940 83%
10 Staffordshire Terrier 8 F February 1.07 1,800 1,134 63%
11 Labrador 32 F April 1 6,970 5,576 80%
12 Labrador 192 F August 0.86 1782 1,550 87%
13* Boxer 48 M May 0.28 182.2 173 95%
14 Kelpie 96 F July 1 4683 4,449 95%
15 Staffordshire Bull Terrier 400 F November 1.28 6825 6,279 92%
16 Cross Bred 192 F April 0.11 4.5 0.23 5%
17 Maltese 96 M March 0.4 1746 1,397 80%
18 Dobermann 44 F June 2.82 6.2 1 13%
19* German Shorthaired-Pointer 288 M March 3.3 7860 4,716 60%
20 Rhodesian Ridgeback 32 F March 0.31 351 260 74%
21 Cross Bred 10 M May 0.86 132 125 95%
22* English Bulldog 16 M November 0.23 15 14 95%
Median 28 401 86%
* Cases 13, 19 and 22 were euthanased at their owner’s request.
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presentation were hyperaesthesia (14 cases), posterior
proprioceptive ataxia (10), hind limb weakness (7), cra-
nial nerve dysfunction (e.g. lack of a menace response,
facial twitching or ocular signs) (7), urinary incontinence
(6), UMN hyperreflexia (5), altered mentation (4) and
muscle atrophy (1). These results are summarised in
Table 2. History and physical findings for each case are
described in detail in Additional file 7: Appendix 7. Two
dogs received avermectins for heartworm prophylaxis in
t h et w ow e e k sp r i o rt os i g n so fN Ae m e r g i n g( C a s e s2
and 20), although signs were probably unrelated in time
to dosing in these instances.
Clinical pathology
Of the 22 dogs, 21 had eosinophilic pleocytosis in CSF
(Figure 4); the remaining dog had an eosinophil count
of 1 cell/μL, with 10% of the count comprising eosino-
phils. A diagnosis of eosinophilic pleocytosis in humans
requires greater than 10% eosinophils of a total CSF cell
count, and also greater than 10 eosinophils/μL, [7,33]
and this definition has been adopted for dogs. Samples
were obtained from the cisterna magna in all dogs
except Cases 16 and 20, which had CSF collected via
lumbar puncture immediately before a caudal myelo-
gram. The median eosinophils count of CSF was 401
cells/μL, while the median percentage eosinophils was
86%. CSF results are summarised in Table 2. Haematol-
ogy was performed concurrently in 10/22 dogs, of which
eight (80%) demonstrated peripheral eosinophilia. No
significant biochemical abnormalities were noted within
the study cohort.
Diagnostic imaging
Myelograms performed in Cases 16 and 20 did not
reveal abnormalities apart from diffuse spinal cord swel-
ling in both instances and rapid clearance of iohexol
from the subarachnoid space in Case 20. Case 18 had
computed tomography (CT) of the head and neck
(before and after intravenous iohexol), with no abnorm-
alities detected.
Treatment outcomes
On the whole, the prognosis was good to excellent, with
death or euthanasia in only 3/22 cases (14%). The length
of prednisolone administration varied from 4 weeks to 3
months. All but four dogs (Cases 13, 18, 19 & 22)
improved rapidly over the initial 48 h and went onto
make a complete recovery. Some dogs received antibio-
tics prior to administration of glucocorticoids, usually
with a view to “covering” the alternative diagnosis of
protozoan myelopathy (neosporosis or toxoplasmosis);
accordingly, clindamycin, trimethoprim-sulpha and pyri-
methamine were the most commonly chosen drugs.
Two dogs (Cases 13 and 22) were euthanased due to
ongoing, unresponsive behavioural problems. Case 13
improved at first but deteriorated over the subsequent 4
months and was euthanased due to inappropriate
aggression. Case 22 was treated for 4 weeks with no
improvement and euthanasia was elected because of
aggression. Case 19 had a two weeks history of aniso-
coria, cervical pain and altered behaviour; cervical pain
resolved with glucocorticoids but ocular signs pro-
gressed to blindness and the dog was euthanased.
Unfortunately none of these dogs were examined at
necropsy following euthanasia. Case 18 presented with
head tremors that proved unresponsive to treatment; its
quality of life was considered adequate and the owners
declined further investigation or treatment.
ELISA data
Controls
Of the 21 dogs in Group A (young pound dogs), 20
(95%) had a measurable titre of anti-A. cantonensis IgG
in serum (Table 3). There was, however, no demon-
strable anti-A. cantonensis IgG in CSF specimens in 20/
21 dogs. The single dog (Control A15) with an antibody
titre in CSF of 100 had the highest serum titre (6,400).
This specimen, along with specimens from Control A8
and Control A13, were contaminated with blood during
collection and this likely accounted for the low CSF
antibody titre detected. Within Group B, 8/22 dogs
(36%) had measurable serum anti-A. cantonensis IgG
(Table 3); CSF was not available from these individuals.
The antibody titres in control group A (young pound
dogs) were substantially higher than titres in the older
hospital patients.
Contemporary NA cases
Of cases where CSF was available for testing, 19/21
(90%) were positive for anti-A. cantonensis IgG using
the ELISA. Of these 19 cases, serum was available for
16, of which 12 were positive also using the ELISA.
Thus, four cases with negative serum titres had positive
IgG titres in CSF. In eight patients, the titre in CSF
exceeded that in serum, whereas in two cases the oppo-
site was true, while in one further patient the titres in
serum and CSF were equal. Two patients (Cases 1 and
3) had serum samples tested one year after the initial
sample (Figure 2). Both were positive, with titres of
1:100 and 1:200, compared to 1:100 and 1:800 at first
admission. Both cases that were negative for CSF anti-
bodies using ELISA were also negative for serum antibo-
dies. These results are summarised in Table 3 and
Figure 5.
Western blot data
Fifteen cases had serum and or CSF submitted for Wes-
tern Blot assay and all reacted to the 31 KDa antigen
band, including one case that was negative on CSF and
serum (Case 20). None of the dogs demonstrated anti-
bodies to the 204 kDa antigen. The results are sum-
marised in Table 4.
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Retrospective case series
One aim of this study was to compare cases published pre-
viously to those seen prospectively. It is clear that there are
a number of differences between the two study cohorts.
When Mason et al. published the first series of NA cases
in 1976 [21], he described a characteristic syndrome affect-
ing pups (less than 20 weeks old) consisting of hind limb
paresis, lumbar hyperaesthesia and urinary incontinence.
Therefore, the entire cohort of 55 cases published in 1983
[14] and the five dogs documented by Collins et al. [32]
were presumptively diagnosed as having NA based on a
combination of almost pathognomonic physical findings.
The diagnosis was then substantiated by CSF cytology
and/or necropsy. Many patients initially exhibited only
one or two of the three signs. Furthermore, many dogs
went onto develop additional signs (e.g. forelimb paresis,
cranial nerve palsies, altered mentation, coma, seizures)
although these were not included as part of the classic
“syndrome”. Thus, the retrospective group could be con-
sidered to have clinical signs of an ascending meningo-
encephalomyelopathy, with conspicuous involvement of
the lumbosacral nerve roots.
In most respects, signs in young puppies mirror those
observed in children, especially infants, perhaps reflect-
ing an immune system inexperienced at dealing with
metazoan parasites, a large synchronous infective dose
of L3 combined with a small vertebral canal, spinal cord
and intervertebral foraminae. In adult humans, NA
tends be self-limiting with mild clinical signs [9],
although there are exceptions. The most common pre-
senting complaints include headache (98%), neck pain
(70%), fever (30%) and vomiting (35%) [10]. Cranial
nerve signs and spinal neuropathy are seen mainly in
children [11], associated with a higher mortality and
increased frequency of permanent neurologic sequelae
[9]. Fatalities although rare, do occur, especially in chil-
dren [11,34,35]. There may also be signs associated with
ingestion and migration of the larvae such as fever,
malaise, vomiting and diarrhoea [36].
Contemporary case series
In comparison to the historical cohort, most dogs in the
contemporary arm of this study did not demonstrate
Mason’st r i a do fs i g n s[ 1 4 ] .H o w e v e r ,t h e ya l ld e m o n -
strated clinical signs consistent with a progressive
meningo-encephalomyelopathy and many presentations
were more reminiscent of the range of signs and symp-
toms seen in adult human patients. Consequently, we
extended our conceptual framework to include NA as a
potential cause of neurologic disease in dogs of any age
with progressive meningo-encephalomyelopathy, eosino-
philic pleocytosis and the presence of anti-A. cantonen-
sis IgG in CSF.
Morbidity and mortality
The recorded cases of NA in pups had a combined mor-
tality rate of 59%, compared to 14% for our contempor-
ary group. The three cases that were euthanased in the
prospective cohort were thought to have had permanent
neurologic deficits and two of these (Cases 13 and 22)
were young. Permanent sequelae are often observed in
human patients with NA, often due to the effects of
granulomas or abscesses that form around dead and
dying larvae or worms in the CNS parenchyma or per-
ipheral (typically cranial) nerves [16,34]. Mason does not
g i v eaf i g u r ef o rt h ep e r c e n t a g eo fs u r v i v i n gp u p p i e s
demonstrating permanent neurologic deficits, but men-
tions it as a common occurrence, with at least one case
euthanased as a result.
Pathophysiology and differential diagnosis
Signs of progressive meningo-encephalomyelopathy are
seen with a number of other diseases, including distem-
per, neosporosis, toxoplasmosis, cryptococcosis and
other fungal diseases; indeed, the list of conditions is
much longer in countries outside Australia [20,37-44].
Table 3 ELISA for control dogs i.e. dogs without NA
Control Group A Control Group B
Case Serum CSF Case Serum
1 1:800 Negative 1 1:800
2 1:400 Negative 2 Negative
3 1:800 Negative 3 1:100
4 1:800 Negative 4 1:100
5 1:200 Negative 5 Negative
6 1:1,600 Negative 6 Negative
7 1:1,600 Negative 7 1:100
8 1:200 Negative 8 Negative
9 1:800 Negative 9 1:100
10 1:800 Negative 10 Negative
11 Negative Negative 11 Negative
12 1:200 Negative 12 Negative
13 1:100 Negative 13 Negative
14 1:800 Negative 14 1:200
15 1:6,400 1:100 15 Negative
16 1:100 Negative 16 1:400
17 1:800 Negative 17 Negative
18 1:800 Negative 18 Negative
19 1:100 Negative 19 Negative
20 1:400 Negative 20 Negative
21 1:400 Negative 21 Negative
22 1:100
Group A dogs were young pound dogs, while Group B were clinical patients
in a veterinary hospital
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in differentiating NA from other diseases. First, large
breed dogs appear over represented, presumably because
they have a greater opportunity to ingest molluscs in a
predominately outdoor domicile. Secondly, there tend to
be a mixture of LMN and UMN signs, the balance
changing with disease progression, with a tendency for
the major “neuroanatomic lesion” to ascend during the
clinical course. Thirdly, hyperaesthesia is the most con-
sistent and conspicuous presenting sign. In our series,
the location and extent of hyperaesthesia was more var-
ied than in cases recorded to date, with cervical pain
more prominent in many cases than lumbar or caudal
hyperaesthesia. In Mason’s series, all cases had posterior
hyperaesthesia, whereas in ours 16/23 dogs (70%) dis-
played hyperaesthesia, but only six with lumbar involve-
ment. Eleven dogs (50%) presented with cervical pain/
nuchal rigidity and in four of these (Cases 1, 8, 11 and
16) this was the only presenting sign. This is reminis-
cent of the picture in adult humans, where the most
common symptoms are headache and neck pain [9].
Hyperaesthesia likely reflects peripheral radiculoneuri-
tis and eosinophilic meningitis. Large areas of eosinophi-
lic infiltration are associated with spinal nerve roots in
experimentally- and naturally-infected dogs [13,14].
Hyperaesthesia may also be associated with migration of
L3 along peripheral nerves, particularly the sciatic nerve;
this has been documented in experimentally infected
dogs, rabbits and mice [13,17,45]. Pneumostrongylus
tenius larvae invade the CNS of Canadian White-tailed
deer via peripheral nerves, especially those in the lumbar
muscles [46]. This migration pattern may occur with A.
cantonensis in dogs and would account for lumbar pain
being a common early sign. Such a neuropathic patho-
mechanism suggests the potential use of gabapentin or
pregabalin as adjunctive drugs for managing pain in
such cases.
Two factors seem critical in determining clinical fea-
tures in a given species: i) the initial infective dose, and
ii) the host’s innate and acquired ability to prevent lar-
vae reaching the CNS. In many non-permissive hosts,
larvae fail to reach the CNS because an effective and
Figure 5 Antibody titres in serum and CSF samples from the retrospective/prospective study cohort. The vertical axis represents the
reciprocal titre of antibodies against A. cantonensis. Serum titres are shown in blue, whereas CSF titres are shown in red. Cases 21 and 22 had
no titre detected using ELISA, but were positive using Western blot analysis for the 31 kDa antigen.
Table 4 ELISA and Western Blot assay results for the
Contemporary Group
Case ELISA (actual
titre)
ELISA (positive v
negative)
Western Blot
Serum CSF Serum CSF
1 1:100 1:800 Positive Positive Positive
2 Negative 1:200 Negative Positive Positive
3 1:800 1:6,400 Positive Positive Positive
4 Negative 1:100 Negative Positive Positive
5 N/A 1:200 N/A Positive N/A
6 Negative 1:800 Negative Positive Positive
7 1:100 1:200 Positive Positive Positive
8 Negative 1:400 Negative Positive Positive
9 N/A 1:400 N/A Positive Positive
10 1:200 1:6,400 Positive Positive N/A
11 N/A 1:3,200 N/A Positive N/A
12 1:12,800 1:6,400 Positive Positive Positive
13 1:400 1:1,600 Positive Positive N/A
14 1:800 1:1,600 Positive Positive Positive
15 1:25,600 1:51,200 Positive Positive N/A
16 1:100 1:100 Positive Positive Positive
17 1:100 1:400 Positive Positive Positive
18 1:100 1:200 Positive Positive Positive
19 1:400 1:200 Positive Positive N/A
20 Negative Negative Negative Positive Positive
21 Negative N/A Negative N/A Positive
22 Negative Negative Negative Negative N/A
Positive (%) 63% 90% 63% 90% 100%
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guinea pigs, calves, pigs and rhesus monkeys can with-
stand dosing with 1000’s of larvae without developing
signs [47-49]. The host’s nutrition status, concurrent
and previous parasite burdens and stress potentially
affect the ability of A. cantonensis larvae to migrate
from gut to CNS. Mason documented numerous young
puppies with concurrent intestinal parasitism [14]. Such
pre-existing infections could compromise mucosal integ-
rity, facilitating penetration of the gut by L3. Interest-
ingly, a number of our cases had a stressful episode
prior to the onset of clinical disease (e.g. surgery, che-
motherapy, immunosuppressive therapy) that may have
adversely affected immune defence mechanisms.
The initial penetration of the gut by L3 is accompa-
nied by vomiting or abdominal pain in many species
[13,15,16] and Mason noted that vomiting often pre-
ceded neurologic signs by 7-10 days. Antecedent alimen-
tary signs were noted in some of our patients. Vomiting
may also occur when neurologic signs develop. The
“incubation period” for NA was generally indetermin-
able. In experimental infections, signs develop 9-14 days
post-inoculation, although the parasite can be seen in
the CNS within three days of ingestion [13,14]. In
humans, the incubation period ranges from 1-36 days,
with an average of 12-16 days [16,50-52]. This period
coincides with the second moult (from L4 to L5 stage
young adults), a time associated with a rise in circulating
immune complexes, enlargement of neural granulomas
and enhanced meningeal inflammation in experimentally
infected animals [53,54].
Epidemiology
There is a trend within both study cohorts for cases to
present from mid-autumn to early winter (April to July).
This has also been observed in human cases occurring
in Brisbane [55]. Although dogs are more likely to
develop NA during this period, cases can present in any
month. Evaluating the two region’s climates, peak inci-
dence coincides with periods of high humidity and
when the average daily temperature ranges from 17°-25°
C (Additional file: Appendix 6). The rate of larval devel-
opment within intermediate hosts depends on ambient
temperature, with an ideal range of 21°-26°C [1]. Once
larvae have matured to the L3 stage, they become quies-
cent and remain viable for the life of the mollusc. In
other regions, seasonal peaks in human NA relate to key
intermediate or paratenic host populations. In Tahiti,
cases are most common when water prawns are abun-
dant [56]; while in New Caledonia, it is when native
molluscs are most numerous [57]. In Thailand, there is
no seasonal peak because small aquatic snails (Pila sp.),
the usual source of infection, are abundant throughout
the year [9].
In dogs, the most likely route of infection is direct
ingestion of an intermediate host. While only one case
in our series (Case 5) was actually seen to eat slugs and
snails, Mason noted that many of his cases had ingested
molluscs. In Australia, a number of species of slugs and
snails can serve as intermediate hosts. These may con-
tain as many as 1000 infective larvae [35]. Larvae remain
viable within a dead intermediate host for as long as 11
days [57]. Mason showed experimentally that pups
would eat slugs even when other food was offered and
suggested that the normal “mouthing” behaviour of pup-
pies might allow ingestion of larvae [14]. Such beha-
viours are less likely to be exhibited by adult dogs, thus
contamination of food may be more important in these
cases. Infective larvae are secreted within the mucus
trails of molluscs and they can survive for several hours
therein, depending on ambient environment [58].
Diagnosis
Definitive diagnosis of NA has historically been made at
necropsy, or by identifying larvae of appropriate mor-
phology within CSF or aqueous humour samples. In the
future, it might be possible to detect cavitations caused
by migrating L3 using high field magnetic resonance
imaging (MRI), as is done in human patients [12], or
using a recently developed PCR assay that detects A.
cantonensis DNA in blood or CSF (see later)[59].
Ten of the previously recorded canine NA cases were
confirmed at necropsy, but none had larvae detected in
CSF specimens. Collection of CSF is easier in humans
than dogs, as there is no requirement for anaesthesia.
Furthermore much larger volumes are obtained and in
several countries repeated lumbar puncture is consid-
ered part of therapy for NA [9,16]. In a series of human
cases, 54% of patients had elevated CSF opening pres-
sures [9]. Increased CSF pressure contributes to clinical
signs, notably headache and neck pain, consequently,
patients may have CSF drained more than once.
Patients, including children, will routinely have up to 25
mL of CSF removed [60,61]. Accordingly, the chance of
recovering larvae is greater than in dogs where typically
2 mL of CSF or less is obtained. Most veterinarians are
hesitant in removing large volumes of CSF from any
patient, due to a perceived risk of the cerebellar hernia-
tion. In Australia, larvae have yet to be identified in the
CSF of human NA patients antemortem, which may
also reflect our physicians’ caution or lower numbers of
larvae in CSF [62].
As most dogs in the contemporary cohort recovered,
diagnosis of NA was based on consistent signs, eosino-
philic pleocytosis in CSF and response to therapy. In all
cases except one (Case 22), the presence of specific IgG
against A. cantonensis provided additional supportive
evidence. The percentage eosinophils and absolute
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with most dogs having both high percentages (> 76%)
and high cell counts (> 1,600 cells/μL). Indeed, in the
retrospective cohort, all dogs had eosinophilic pleocyto-
sis. In the contemporary cohort, however, two dogs
(Cases 16 and 18) had < 10 eosinophils/μL. Case 16 dis-
played signs consistent with progressive meningo-ence-
phalomyelitis and responded to glucocorticoids, while
neurologic signs in Case 18 persisted despite treatment;
both dogs were positive for A. cantonensis IgG in serum
and CSF using ELISA and Western blots. Therefore,
despite these dogs not having met the strict criteria for
eosinophilic pleocytosis, they were still considered to
have NA. Similar conclusions were made in a recent
outbreak of human NA in Taiwan, with only 12/17
cases (71%) developing eosinophilic pleocytosis [61].
Interestingly, of these 12 cases, only 5 initially had eosi-
nophilic pleocytosis; the remaining 7 developed it over
the subsequent 10 days (despite some patients receiving
glucocorticoids). Thus, lack of eosinophilic pleocytosis
should not rule out NA. Indeed, based on experimental
observations, some animals with NA are expected to not
demonstrate eosinophilic pleocytosis if CSF is collected
too early, or too late. Extrapolating from the human
experience, several of our dogs had sub-acute to chronic
clinical disease (e.g. cases 13 and 22). In these patients,
the initial florid inflammatory response may have dissi-
pated by the time CSF was collected. If signs were
indeed referable to late sequelae, the poor response to
treatment would be explicable.
Eight of the 10 dogs in the contemporary cohort
tested had a peripheral eosinophilia and similar observa-
tions were made in Mason’s series, although he did not
reproduce this in experimentally-infected dogs [14]. All
dogs in Mason’s series with peripheral eosinophilia also
had intestinal parasites. None of the dogs in our con-
temporary series had faecal samples examined for para-
sites. In humans, peripheral eosinophilia is commonly
seen with NA and these patients generally have no evi-
dence of intestinal parasitism [9]. Not all ingested larvae
reach the host’s CNS, so some must die in other tissues,
presumably inciting an eosinophilic granulomatous reac-
tion [1,13,14,47]. Such a mechanism would account for
the peripheral eosinophilia noted in our series.
Advanced imaging is useful in human NA [63-65], but
has yet to be of proven benefit in canine NA. Three of
the prospective cohort had myelography or a CT study
(Cases 1, 18 and 19) but no definitive abnormalities
were detected. In human patients, MRI appears to be
the superior imaging modality for diagnosing NA,
although multi-slice helical CT can sometimes resolve
verminous granulomas e.g. along the optic nerve. High
field MRI scanners (> 1.5 T) using paramagnetic con-
trast agents can display images of individual larvae and/
or migration tracts in the neural parenchyma [12].
Lesions may not be evident at the time of presentation
a n da c t u a l l yc a nb em o s tv i s i b l ea f t e rt h ep a t i e n th a s
b e g u nt oi m p r o v e ,t a k i n gm a n ym o n t h st or e s o l v e
[65-67].
Some parasitic infections can be diagnosed by demon-
strating patency. Specifically for A. vasorum, faecal ana-
lysis using the Baerman technique yields L1 in faeces
and bronchial washings of symptomatic dogs and foxes
because parasites matures to the reproductive stage [68].
However, as A. cantonensis can only become patent in
rats [13,45,47,69-71], faecal analysis is of no value for
diagnosing canine NA.
Detection of anti-A. Cantonensis antibodies
Serum ELISA
ELISA testing of serum using a crude antigen prepara-
t i o nw a sn o ts e n s i t i v eo rs p e c i f i ca td i a g n o s i n gN A .
Only 12/19 dogs (63%) with NA had positive serum
titres, compared to 28/43 (65%) of control dogs. Two
dogs with NA (Cases 1 and 3) had serum samples tested
one year after initial presentation; both remained posi-
tive, albeit with low titres. Thus, IgG titres likely persist
for several months following infection (although the
dogs might have been re-exposed). It is possible that
some control dogs were positive because they had been
previously exposed to the A. cantonensis,d e v e l o p i n g
subclinical self-limiting infections and a successful
immune response.
A 1980 seroepidemiologic study suggested a substan-
tial level of subclinical A. cantonensis infections in
Aboriginal people in northern Australia [72], but lack of
controls and use of a crude antigen for testing raised
concerns about the validity of these findings. Indeed, a
high level of cross-reaction with other nematode infec-
tions (e.g. Stongyloides stercoralis, visceral larval migrans
of Toxocara canis) seems more likely [62]. The use of a
crude antigen in our ELISA would also have the poten-
tial for a significant level of cross-reaction when using
serum, the high percentage of control cases with posi-
tive titres simply reflecting cross-reaction with other
helminths (Toxocara canis, Ancylostoma caninum, Tri-
churis vulpis, etc.), especially in young dogs. In a serolo-
gical study of NA in macropods using the same ELISA,
a substantial number of false positives in control groups
were observed from macropods in areas where A. canto-
nensis is not considered endemic [25]. Again, the most
likely explanation was cross-reaction with other nema-
todes. For this reason, numerous immunologic tests for
NA have been abandoned, including indirect haemag-
gultination [73], intradermal testing [74] and comple-
ment fixation [75]. At least 25 antigens from adult A.
cantonensis are shared with other helminths [76] and
substantial cross reactivity exists amongst larval stages
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titres in serum of our NA cases probably has, in part, a
similar explanation.
CSF ELISA and western blots
ELISA testing using CSF appears much more promising
as a means of diagnosing NA. Antibodies against A. can-
tonensis in CSF are expected to be incited by the pre-
sence of larvae within the CNS and produced locally, as
the blood brain barrier is normally impermeable to IgG
in the circulation. Positive results were observed in 19/
21 NA cases (90%), but in only one of the control group
(a CSF specimen contaminated by blood during collec-
tion). The latter chance finding emphasises that high
IgG levels in serum may give rise to false positive results
if there is contamination of CSF with blood. Testing of
CSF samples from dogs with other inflammatory or neo-
plastic neurological diseases would be useful to further
determine the sensitivity and specificity of the ELISA.
Four dogs with intervertebral disc disease (confirmed by
myelography and surgery) had CSF tested using the
ELISA and were negative (data not shown). A larger
number of specimens from cases with other CNS dis-
eases would make the observation more compelling.
All cases in the prospective cohort tested using Wes-
tern Blot analysis (14 cases) were positive. Interestingly,
dogs did not make IgG to the 204 kDa antigen but
reacted strongly to the 31 kDa antigen, while macropods
reacted to both antigens (like rats and human patients)
[25,31]. Unfortunately, no CSF specimens from control
dogs were subjected to Western blot analysis, but con-
trol macropod serum tested negative, as expected. Using
macropod serum, Western blots using the 31 kDa anti-
gen had a sensitivity of 62% and specificity of 92% [25].
The most critical limitation of Western blot testing in
the macropod study was the number of false negatives,
but the rarity of false positives suggests its use as a con-
firmatory technique in dogs with suspect NA is valid.
The recent development of a genus specific polymer-
ase chain reaction (PCR) [59] and loop-mediated iso-
thermal amplification (LAMP) [79] tests for
Angiostrongylus species is of great interest, and such a
test might be suitable for diagnosing of NA using whole
blood, CSF or tissue obtained at necropsy. PCR testing
is already proving useful for diagnosis of A. vasorum
infections in dogs in the UK [59,80].
Treatment
Role of glucocorticoids
All dogs in the prospective cohort received glucocorti-
coids. Reducing inflammation associated with dead or
moulting A. cantonensis larvae should improve signs in
dogs with eosinophilic meningo-encephalomyelitis. This
was certainly true for our cases, except in four dogs
(described below). The response to glucocorticoids was
rapid and most dogs improved substantially within two
days. In particular, hyperaesthesia was conspicuously
improved. In contrast, the historical cohort demon-
strated a very high rate of mortality despite glucocorti-
coid therapy, possibly because of heavier infections in
immunologically näive patients with small vertebral
canals and spinal cords.
In dogs that ingest numerous larvae, using corticos-
teroids to dampen the immune response may not, in
itself, result in a favourable outcome. In fact, the dis-
ease may progress due to continued larval migration,
unhindered by the host’s immune response. Several
dogs in the historical cohort worsened despite treat-
ment with glucocorticoids, possibly due to this phe-
nomenon. Clearly, mechanical damage due to
migrating larvae and inflammation secondary to the
appropriate host immune response both contribute to
neural damage [43,66,81-85]. Which of the two is the
more significant depends on (i) the age, species and
breed of the infected host, (ii) the number of larvae
ingested and the time course over which infection
occurs, (iii) the physical dimensions of the spinal cord
and nerve roots. In very young dogs, like those in
Mason’s series, it may be that the immune system is
simply overwhelmed and the large number of migrat-
ing larvae (and secondary inflammation) produce over-
whelming trauma to neural tissues and such pups die
or must be euthanased. Similar considerations apply to
an even greater extent in tawny frogmouths (an owl or
jay-like Australian native bird) because of their extre-
m e l ys m a l ls p i n a lc o r d .
Of the four patients in the contemporary cohort that
did not respond to glucocorticoids therapy, two dogs
(Cases 13 and 22) presented for chronic progressive
CNS signs including behavioural changes. Both were
eventually euthanased due to intractable aggression that
developed after treatment. Another dog (Case 18) had a
6-month history of head tremors unresponsive to ther-
apy, while a fourth dog (Case 19) presented for cranial
nerve dysfunction, cervical pain, progressing to blind-
ness. Unfortunately, necropsy confirmation was not pos-
sible in these cases, which limits inferences that can be
made. Indeed, it is possible that these dogs had other
CNS diseases. In the retrospective cohort, a number of
pups failed to fully recover and had persistent hind limb
paresis. Permanent sequelae are seen in human NA, par-
ticularly in children, and include blindness, altered men-
tation and facial nerve palsies [35,60]. Jindrak was able
to demonstrate, in dogs, that granulomas associated
with larval fragments were present in the CNS 60 days
post-infection [13], but by 90 days, lesions were no
longer evident. In humans, MRI demonstrate lesions
within the CNS for up to 22 weeks post-infection [65].
Thus, the length of corticosteroid therapy should
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need to be extended.
There are potential complications associated with
long-term administration of corticosteroids. Two dogs
in the contemporary group (Cases 2 and 3) were smaller
than litter mates at the cessation of treatment, and at
maturity appeared under-sized for their respective
breeds. Studies on the growth of children receiving cor-
ticosteroids have shown that some fail to grow to their
expected height [86]. Secondary infections are another
complication of long-term corticosteroid use. Case 4
developed demodectic mange during treatment, which
was successfully managed with topical therapy. Translo-
cated enteric bacterial infections have been described
secondary to parasites migrating from the GIT [87].
Long-term glucocorticoid therapy would further increase
the risk of infections, thus broad-spectrum antibiotics
are justified in these patients.
Role of anthelmintics
There is a history of scepticism regarding the place of
anthelmintics in managing veterinary NA cases. If
pathology is due predominantly to the host’s reaction to
larvae, then giving anthelmintics soon after infection
should hasten the onset of signs. Similarly, administer-
ing anthelmintics during the natural course of the dis-
ease might worsen the inflammatory response. In
Mason’s study, 8 of 55 pups received anthelmintics
without concomitant glucocorticoids, all amongst the
most severely affected of the cohort; six died or where
euthanased and the remaining two pups had prolonged
recoveries [14]. The conclusion was that anthelmintics
worsened clinical outcomes, because they synchronise
the release of metazoan antigens.
In human medicine, the practice of administering
anthelmintics is an accepted part of therapy for NA in
many Asian countries. The rationale is that in severe
cases there is a significant component of neural damage
due to mechanical injury by migrating larvae [16]. There
is also evidence that vascular lesions (thrombosis, aneur-
ysms) occur secondary to larval migration [16]. Anthel-
mintics have been used successfully in other species to
treat NA [88,89]. Two cases (see Additional file 4:
Appendix 4) that did not meet the inclusion criteria for
our study are worthy of comment. In a litter of seven
Greyhound pups with multifocal CNS disease, six died
despite glucocorticoid therapy, but a single pup treated
with fenbendazole as well as glucocorticoids recovered.
Necropsy of one of the littermates that died demon-
strated numerous A. cantonensis larvae within the cord,
brain and meninges. The second case, a 3-month female
Boxer, had been treated with corticosteroids and iver-
mectin for three weeks for presumptive NA. At referral,
the dog had eosinophilic pleocytosis in CSF (111 cells/
μL; 85% eosinophils). Ivermectin was stopped. Although
the dog initially improved over a 2-week period, seven
weeks after referral it relapsed despite a tapering gluco-
corticoid regimen and was euthanased. Necropsy
revealed A. cantonensis larvae within the spinal cord
and brain. These cases suggest that administration of
anthelmintics may be useful in treating NA, if combined
with corticosteroids and other immune modulators.
Experimentally, immunosuppression reduces meningitic
signs but worsens myelo-encephalitic disease by inhibit-
ing eosinophil function [85]. The use of anthelmintics
therefore seems cogent [82,90]. An escalating dosage
regimen that kills larvae slowly and non-synchronously,
in conjunction with glucocorticoids, has theoretical
merit. Such an approach has been used successfully in a
recent paediatric patient treated in Sydney in 2011 (Pro-
fessor Alison Kesson, personal communication).
Adjunctive therapy
All dogs in our study received symptomatic and suppor-
tive care. Such care is critical, as is management of
hyperaesthesia. Mu opioid agonists (e.g. morphine,
methadone, buprenorphine) are useful adjuncts to glu-
cocorticoids for treating hyperaesthesia [91], and drugs
effective for neuropathic pain (gabapentin, pregabalin)
might also be useful adjuncts. Manual expression of the
bladder or urinary catheterisation may be required in
some instances. Padded bedding is important for
severely affected patients, as is nursing in sternal recum-
bency to optimise lung function. Fluid therapy is indi-
cated if the dog cannot drink or if there is a risk of
aspiration. Physiotherapy and massage during convales-
cence will help minimise muscle wasting or contracture,
although care must be taken with hyperaesthetic
animals.
Cyclosporine was helpful in a mouse model of NA
[92]. The benefits appear to be twofold: i) its effect on T
cells reduces the host’s immune response, particularly
eosinophil recruitment and ii) it has a direct anti-parasi-
tic effect. The micro-emulsion formulation of cyclospor-
ine has reduced the need for drug monitoring and a
dose of 5 mg/kg daily is safe in virtually all dogs [93].
To date, there are no reports of human cases receiving
cyclosporine. Other drugs that modify the TH1a n dT H2
responses may also be beneficial, such as tumour necro-
sis factor-a inhibitors, e.g. thalidomide [94]. Matrix
metalloproteinases play a critical role in CNS inflamma-
tion [83,95] and their inhibition reduced the severity of
NA lesions in mice [96,97]. A number of drugs, includ-
ing doxycycline and albendazole, inhibit metalloprotei-
nases and such agents may be useful in treating NA
[90,96].
Prevention
In other species, acquired immunity appears to be short
lived or incapable of preventing re-infection [98-101].
Firm recommendations cannot be made with regard to
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Page 14 of 18preventing NA in dogs using anthelmintics. There is no
evidence that routine heartworm or intestinal prophy-
laxis prevents NA, although they do prevent patent
infections with the closely related A. vasorum.M o s t
anthelmintics used for routine heartworm or intestinal
prophylaxis are administered monthly and most drugs
(ivermectin, selamectin, milbemycin) attain therapeutic
levels in blood for less than 48 h. Because A. cantonensis
larvae can be seen in the CNS within hours to days fol-
lowing ingestion [1], anthelmintics would need to be
present in circulation continuously to be an effective
prophylactic. Following dermal administration of a com-
bination product (Advocate; Bayer) containing moxidec-
tin and imidacloprid, moxidectin takes 4-10 days for
maximum concentrations in the serum to be reached,
with substantial levels persisting in the blood for 28
days. Thus this combination “spot on” product, if given
frequently enough (perhaps every 2 weeks), or the moxi-
dectin in peanut oil depot formulation (Proheart; Pfizer
Animal Health), might provide effective prophylaxis.
Experimental studies looking at the efficacy of such pro-
ducts in this setting would be helpful.
Environmental control of definitive and intermediate
hosts represents the most effective approach to reducing
the likelihood of infection. Preventing contamination of
food and food containers, clearing out areas that might
harbour rats, limiting access to gardens where slugs and
snails may reside and good hygiene would all limit expo-
sure of dogs to potential sources of infection. This
would also reduce the risk to clients and their children.
Further, the safe use of anti-coagulant rodenticides (to
reduce rat numbers) and molluscicides (to reduce snail
and slug numbers) in the environment should minimise
the risk to adult dogs. For puppies, perhaps the best
prevention is to keep them indoors or under close
supervision outdoors. It might be prudent to dose pups
with moxidectin should they be presented within 1-2
days of eating slugs or snails. Importantly, dogs with
NA should be considered sentinels in the prevention of
human NA.
Comparisons with A. vasorum
In the UK, A. vasorum has behaved as an emerging
infectious disease over the last 15 years or so, becoming
more prevalent overall and extending its natural range
into new districts from focal enzootic foci
[59,80,102,103]. Historically, the disease was most com-
mon in the south, but its range is extending northwards
into Scotland [102]. It is generally thought that both
foxes and snails play a critical part in the epidemiology
of this disease. Perhaps global warming or changes in
the epidemiology of the UK canid population, including
its genetic constitution and movement of pets back and
forth from Europe may have changed the distribution of
cases and clinical spectrum of disease observed in the
UK [102].
In Australia, the geographic range of A. cantonensis
is extending southwards. In the 1970s, it was consid-
ered a tropical disease seen only in Queensland,
whereas now it is seen commonly in New South
Wales. Surveys of rats and molluscs have established
that the range of A. cantonensis extends at least as far
south as Jervis Bay on the south coast of New South
Wales [104], although it seems likely that the distribu-
tion of this parasite has and will spread further south.
In Australia, pet dogs and tawny frogmouths appear to
be the two key sentinel species. In Sydney, disease was
first reported in dogs in 1992, whereas the first human
cases were reported in 2003 [105]. We have recently
heard anecdotal data suggesting NA is present in dogs
in Samoa (Belinda Hamlin, personal communication),
and it seems likely it is present but currently unrecog-
nised in other Pacific Islands (Micronesia, Polynesia,
Hawaii), south east Asia, the Caribbean and possibly
even Louisiana [58,106,107].
There are many parallels between the epidemiology of
A. vasorum and A. cantonensis in the UK and Australia,
respectively, and likely we can learn more (e.g. about
molecular diagnostics and strategies concerning disease
prevention) by continuing to compare and contrast
these two clinical entities.
Endnotes
A Four additional cases in Collins et al. [32] from Syd-
ney had adequate clinical and demographic data, but
CSF was not collected. Two 12-week-old German shep-
herd pups were presented for generalised hyperaesthesia
and hind limb weakness. They developed pyrexia and
Figure 6 Haematoxylin and eosin stained section of the brain
of a greyhound pup that died of neural angiostrongylosis.
Note the nematode larvae (arrow) in transverse section on the
middle of the neuropile.
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Page 15 of 18diarrhoea and were treated with flunixin and an anti-
diarrheal mixture and made a complete recovery. Three
weeks later, two more puppies, aged 5-weeks, presented
for generalised hyperaesthesia, diarrhoea and hind limb
weakness and died soon thereafter. A. cantonensis larvae
were recovered from the spinal cords and cerebellum of
both puppies in association with eosinophilic granulo-
matous inflammation.
B A litter of six greyhound puppies with NA did not
meet the entry criteria as CSF specimens were unavail-
able. Five developed hind limb paralysis, urinary and fae-
cal incontinence and severe hyperaesthesia. Four died
within three days of developing signs. At necropsy, one
pup had granulomatous encephalitis with the occasional
nematode within the granulomas (Figure 6). The dogs
had been moved to a new kennel, which was near a for-
mer rats nest, and there were many snails around the
dogs’ run.
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